Who owns Milestone Pharmaceuticals Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MIST from SEC Form 13F filings across 78 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 78 institutions disclosed 49.6M shares of Milestone Pharmaceuticals Inc. worth $66.4M — about 35.7% of shares outstanding; the largest disclosed holder is Pavaki Capital Management LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
78
13F holders
$66.4M
value, 2026 filers
35.7%
of shares outstanding (49.6M sh)
8
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MIST's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Pavaki Capital Management LLCNEW | 9.1M | $12.2M | 4.2% | 6.5% | new |
| 2 | RTW INVESTMENTS, LP | 7.8M | $10.5M | 0.1% | 5.6% | +23.7% |
| 3 | Propel Bio Management, LLC | 7.4M | $10.0M | 5.2% | 5.4% | +80.4% |
| 4 | Point72 Asset Management, L.P. | 5.4M | $7.3M | 0.0% | 3.9% | +398.4% |
| 5 | Simplify Asset Management Inc. | 3.3M | $4.5M | 0.1% | 2.4% | +122.3% |
| 6 | MILLENNIUM MANAGEMENT LLC | 3.1M | $4.2M | 0.0% | 2.3% | +103.5% |
| 7 | TWO SIGMA INVESTMENTS, LP | 2.0M | $2.7M | 0.0% | 1.5% | -12.0% |
| 8 | MARSHALL WACE, LLP | 1.8M | $2.4M | 0.0% | 1.3% | -7.6% |
| 9 | Kalehua Capital Management LLCNEW | 1.3M | $1.7M | 1.2% | 0.9% | new |
| 10 | Lion Point Capital, LP | 820,000 | $1.1M | 5.3% | 0.6% | 0.0% |
| 11 | TORONTO DOMINION BANK | 750,000 | $1.0M | 0.0% | 0.5% | 0.0% |
| 12 | Boxer Capital Management, LLC | 666,666 | $893,332 | 0.1% | 0.5% | 0.0% |
| 13 | AMERIPRISE FINANCIAL INCNEW | 666,666 | $893,332 | 0.0% | 0.5% | new |
| 14 | MORGAN STANLEY | 635,211 | $851,183 | 0.0% | 0.5% | -12.3% |
| 15 | UBS Group AG | 465,403 | $623,641 | 0.0% | 0.3% | -6.0% |
| 16 | BOOTHBAY FUND MANAGEMENT, LLC | 462,669 | $619,976 | 0.0% | 0.3% | +174.3% |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 359,895 | $482,259 | 0.0% | 0.3% | -30.7% |
| 18 | GUARDIAN WEALTH ADVISORS, LLC / NC | 339,450 | $454,863 | 0.0% | 0.2% | +21.1% |
| 19 | Aptus Capital Advisors, LLC | 339,450 | $454,863 | 0.0% | 0.2% | +21.1% |
| 20 | Seven Fleet Capital Management LP | 270,233 | $362,112 | 0.1% | 0.2% | -18.9% |
| 21 | Squarepoint Ops LLC | 231,824 | $310,644 | 0.0% | 0.2% | -31.2% |
| 22 | LPL Financial LLC | 220,873 | $295,970 | 0.0% | 0.2% | +14.2% |
| 23 | Balyasny Asset Management L.P. | 220,498 | $295,467 | 0.0% | 0.2% | -74.1% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 173,704 | $232,763 | 0.0% | 0.1% | -1.6% |
| 25 | TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 150,000 | $201,000 | 0.1% | 0.1% | +50.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.